Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Net Income (2024 - 2025)

Historic Net Income for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to -$1.9 million.

  • Xilio Therapeutics' Net Income rose 8693.27% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.8 million, marking a year-over-year change of. This contributed to the annual value of -$60.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Xilio Therapeutics' Net Income is -$1.9 million, which was up 8693.27% from -$14.4 million recorded in Q2 2025.
  • Over the past 5 years, Xilio Therapeutics' Net Income peaked at -$1.9 million during Q3 2025, and registered a low of -$14.8 million during Q3 2024.